Related references
Note: Only part of the references are listed.Compound dataset and custom code for deep generative multi-target compound design
Thomas Blaschke et al.
FUTURE SCIENCE OA (2021)
Analysis of Biological Screening Compounds with Single- or Multi-Target Activity via Diagnostic Machine Learning
Christian Feldmann et al.
BIOMOLECULES (2020)
Systematic Data Analysis and Diagnostic Machine Learning Reveal Differences between Compounds with Single- and Multitarget Activity
Christian Feldmann et al.
MOLECULAR PHARMACEUTICS (2020)
Memory-assisted reinforcement learning for diverse molecular de novo design
Thomas Blaschke et al.
JOURNAL OF CHEMINFORMATICS (2020)
Direct steering of de novo molecular generation with descriptor conditional recurrent neural networks
Panagiotis-Christos Kotsias et al.
NATURE MACHINE INTELLIGENCE (2020)
Exploring the GDB-13 chemical space using deep generative models
Josep Arus-Pous et al.
JOURNAL OF CHEMINFORMATICS (2019)
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Xin Yang et al.
CHEMICAL REVIEWS (2019)
Prediction of Different Classes of Promiscuous and Nonpromiscuous Compounds Using Machine Learning and Nearest Neighbor Analysis
Thomas Blaschke et al.
ACS OMEGA (2019)
Has Drug Design Augmented by Artificial Intelligence Become a Reality?
Hongming Chen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Randomized SMILES strings improve the quality of molecular generative models
Josep Arus-Pous et al.
JOURNAL OF CHEMINFORMATICS (2019)
Hit Dexter 2.0: Machine-Learning Models for the Prediction of Frequent Hitters
Conrad Stork et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Generative Recurrent Networks for De Novo Drug Design
Anvita Gupta et al.
MOLECULAR INFORMATICS (2018)
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Marwin H. S. Segler et al.
ACS CENTRAL SCIENCE (2018)
The rise of deep learning in drug discovery
Hongming Chen et al.
DRUG DISCOVERY TODAY (2018)
Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease
Asha Hiremathad et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Rational application of drug promiscuity in medicinal chemistry
Yicheng Mei et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Machine Learning Distinguishes with High Accuracy between Pan-Assay Interference Compounds That Are Promiscuous or Represent Dark Chemical Matter
Swarit Jasial et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A perspective on multi-target drug discovery and design for complex diseases
Rona R. Ramsay et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
The ChEMBL database in 2017
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2017)
PubChem BioAssay: 2017 update
Yanli Wang et al.
NUCLEIC ACIDS RESEARCH (2017)
Computational Multitarget Drug Design
Weilin Zhang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
The Ecstasy and Agony of Assay Interference Compounds
Courtney Aldrich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Molecular de-novo design through deep reinforcement learning
Marcus Olivecrona et al.
JOURNAL OF CHEMINFORMATICS (2017)
Entering the 'big data' era in medicinal chemistry: molecular promiscuity analysis revisited
Ye Hu et al.
FUTURE SCIENCE OA (2017)
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
Michael K. Gilson et al.
NUCLEIC ACIDS RESEARCH (2016)
Multitarget Drug Discovery and Polypharmacology
Maria Laura Bolognesi et al.
CHEMMEDCHEM (2016)
In silico methods to address polypharmacology: current status, applications and future perspectives
Antonio Lavecchia et al.
DRUG DISCOVERY TODAY (2016)
ZINC 15-Ligand Discovery for Everyone
Teague Sterling et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
An Aggregation Advisor for Ligand Discovery
John J. Irwin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
De Novo Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy
Erchang Shang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Polypharmacology: Challenges and Opportunities in Drug Discovery
Andrew Anighoro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
SuperPred: update on drug classification and target prediction
Janette Nickel et al.
NUCLEIC ACIDS RESEARCH (2014)
Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus
Daniel Reker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Rules for Identifying Potentially Reactive or Promiscuous Compounds
Robert F. Bruns et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
From in silico target prediction to multi-target drug design: Current databases, methods and applications
Alexios Koutsoukas et al.
JOURNAL OF PROTEOMICS (2011)
Extended-Connectivity Fingerprints
David Rogers et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
Jonathan B. Baell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Selectively Nonselective Kinase Inhibition: Striking the Right Balance
Richard Morphy
JOURNAL OF MEDICINAL CHEMISTRY (2010)
PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach
Xiaofeng Liu et al.
NUCLEIC ACIDS RESEARCH (2010)
Toxicity Testing in the 21st Century: Implications for Human Health Risk Assessment
Robert J. Kavlock et al.
RISK ANALYSIS (2009)
Ligand-Target Prediction Using Winnow and Naive Bayesian Algorithms and the Implications of Overall Performance Statistics
Florian Nigsch et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
Discovery of Multitarget Inhibitors by Combining Molecular Docking with Common Pharmacophore Matching
Dengguo Wei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
How to design multi-target drugs: target search options in cellular networks
Tamas Korcsmaros et al.
EXPERT OPINION ON DRUG DISCOVERY (2007)
Multi-target therapeutics: when the whole is greater than the sum of the parts
Grant R. Zimmermann et al.
DRUG DISCOVERY TODAY (2007)
Opinion - How many drug targets are there?
John P. Overington et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases
Nidhi et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Computer-based de novo design of drug-like molecules
G Schneider et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening
SL McGovern et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
PASS: prediction of activity spectra for biologically active substances
A Lagunin et al.
BIOINFORMATICS (2000)
Share Paper
